Bio-Medical Applications Of Mississippi, Inc in Rolling Fork, Mississippi - Dialysis Center

Bio-Medical Applications Of Mississippi, Inc is a medicare approved dialysis facility center in Rolling Fork, Mississippi and it has 10 dialysis stations. It is located in Sharkey county at 20019 Hwy 61 South, Rolling Fork, MS, 39159. You can reach out to the office of Bio-Medical Applications Of Mississippi, Inc at (662) 873-2272. This dialysis clinic is managed and/or owned by Fresenius Medical Care. Bio-Medical Applications Of Mississippi, Inc has the following ownership type - Profit. It was first certified by medicare in October, 1998. The medicare id for this facility is 252555 and it accepts patients under medicare ESRD program.

Name	Bio-Medical Applications Of Mississippi, Inc
Location	20019 Hwy 61 South, Rolling Fork, Mississippi
No. of Dialysis Stations	10
Medicare ID	252555
Managed By	Fresenius Medical Care
Ownership Type	Profit
Late Shifts	Yes

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with Bio-Medical Applications Of Mississippi, Inc from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number	1083724298
Doing Business As	Rcg Of Mayersville, Llc
Address	20019 Highway 61 Rolling Fork, Mississippi, 39159
Phone Number	(662) 873-2272

NPI Number	1437518776
Organization Name	Fresenius Kidney Care Rolling Fork Dialysis
Doing Business As	Bio-medical Applications Of Mississippi, Inc.
Address	20019 Highway 61 Rolling Fork, Mississippi, 39159
Phone Number	(662) 873-2272

Dialysis patients with Hemoglobin data	21
Medicare patients who had average hemoglobin (hgb) less than 10 g/dL	19

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

• Hemodialysis

  Adult patients getting regular hemodialysis at the center	35
  Adult patient months included in Kt/V greater than or equal to 1.2	338
  Percentage of adult patients getting regular hemodialysis at the center	96
  Percentage of pediatric patients getting regular hemodialysis at the center

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Bio-Medical Applications Of Mississippi, Inc with elevated calcium levels.

Patients with hypercalcemia	35
Hypercalcemia patient months	338
Patients with Serumphosphor	36
Patients with Serumphosphor less than 3.5 mg/dL	8
Patients with Serumphosphor from 3.5 to 4.5 mg/dL	29
Patients with Serumphosphor from 4.6 to 5.5 mg/dL	32
Patients with Serumphosphor from 5.6 to 7 mg/dL	23
Patients with Serumphosphor greater than 7 mg/dL	7

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries	36
Patient months included in arterial venous fistula and catheter summaries	317
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment	80
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer	3

The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.

Standard Hospitalization Summary Ratio(SHR) Year	January, 2016 - December, 2016
Patients in facility's Hospitalization Summary	42
Hospitalization Rate in facility	146.6 (As Expected)
Hospitalization Rate: Upper Confidence Limit	301.6
Hospitalization Rate: Lower Confidence Limit	75

The rate of readmission show you whether patients who were being treated regularly at Bio-Medical Applications Of Mississippi, Inc were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.

Standard Readmission Summary Ratio(SRR) Year	January, 2016 - December, 2016
Readmission Rate in facility	30.2 (As Expected)
Readmission Rate: Upper Confidence Limit	45.3
Readmission Rate: Lower Confidence Limit	17.8